Multiple Sclerosis
Multiple Sclerosis
Calabrese V, Raffaele R, Cosentino E, Rizza V. Changes in cerebrospinal fluid levels of malondialdehyde and GSH reductase activity in multiple sclerosis. International Journal of Clinical Pharmacology Research 14(4):119-123, 1994 Medline
Clausen J, Jenson GE, Nielsen SA. Selenium in chronic neurologic disease. Multiple sclerosis and Batten’s disease. Biological Trace Element Research 15:179-203, 1988 Medline
Guy J, Ellis EA, Hope GM, Rao NA. Antioxidant enzymes reduce loss of blood-brain barrier integrity in experimental optic neuritis. Archives of Ophthalmology 107(9): 1359-63, 1989 Medline
Jenner P. Oxidative damage in neurodegenerative disease. Lancet 344(8925); 796-8, 1994 Medline
Jensen GE, Clausen J. Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis. J. Neurol. Sci. 63: 45-53, 1984 Medline
Karg E, Klivenyi P, Nemeth I, et al. Nonenzymatic antioxidants of blood in multiple sclerosis. J. Neurol. 246: 533-539, 1999 Medline
Knight JA. Reactive oxygen species and the neurodegenerative disorders. Annals of Clinical Laboratory Science 27(1):11-25, 1997 Medline
Korpela H, Kinnunen E, Jentunen J, Kumulainen J, Koskenvuo M. Serum selenium concentration, glutathione peroxidase activity and lipid peroxides in a co-twin control study on multiple sclerosis. Journal of the Neurological Sciences 91(1-2):79-84, 1989 Medline
Langemann H, Kabiersch A, Newcombe J. Measurement of low-molecular-weight anti-oxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. European Neurology 32(5):248-252, 1992 Medline
Le Vine. The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Medical Hypothesis 39(3):271-274, 1992 Medline
Mai J, Sorenson PS, Hansen JC. High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety and absorption of selenium. Biological Trace Element Research 24(2):109-117, 1990 Medline
Mazzella GL, Sinforiani E, Savoldi F, Allegrini M, Lanzola E, Scelsi R. Blood cells glutathione peroxidase activity and selenium in multiple sclerosis. European Neurology 22(6):442-446, 1983 Medline
Polidoro G, Di Ilio C, Arduini A, La Rovere G, Federici G. Superoxide dismutase, reduced glutathione and TBA-reactive products in erythroctes of patients with multiple sclerosis. International Journal of Biochemistry 16(5):505-509, 1984 Medline
Ronquist G, Frithz G. Adenylate kinase activity and glutathione concentration of cerebrospinal fluid in different neurological disorders. European Neurology 18(2):106-110, 1979 Medline
Shukla VK, Jensen GE, Clausen J. Erythrocyte glutathione peroxidase deficiency in multiple sclerosis. Acta Neurology Scandinavia 56(6): 542-550, 1977 Medline
Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annual Review of Pharmacology & Toxicology 36:83-106,1996 Medline
Singh I, Pahan K, Khan M, Singh AK. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J. Biol. Chem 273: 20354-20362, 1998 Medline
Szeinberg A, Golan R, Ben Ezzer J, Sarova-Pinhas I, Sadeh M, Braham J. Decreased erythrocyte GSH peroxidase activity in multiple sclerosis. Acta Neurology Scandinavia 60(5): 265-271, 1979 Medline
Toshniwal PK, Zarling EJ. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochemistry Research 17(2): 205-207, 1992 Medline